Synthesis of γ-hydroxyalkyl substituted piperidine iminosugars from D-glucose

Journal of Organic Chemistry

Volumn 73, Issue 8, 2008, Pages 3284-3287

  Mane, Rajendra S ^a   Kumar, K S Ajish ^a   Dhavale, Dilip D ^a  

^a UNIVERSITY OF PUNE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDES; ENANTIOMERS; GLUCOSE; HYDROLYSIS;

AMINOCYCLIZATION; IMINOSUGARS;

SYNTHESIS (CHEMICAL);

ALDEHYDE; ALKYL GROUP; AMINE; CARBOHYDRATE DERIVATIVE; GLUCOSE; HYDROXYL GROUP; IMINE; PIPERIDINE; PIPERIDINE DERIVATIVE;

ARTICLE; CYCLIZATION; ENANTIOMER; HYDROLYSIS; REACTION ANALYSIS; REDUCTION; SYNTHESIS;

ALKYLATION; GLUCOSE; HYDROXYLATION; IMINO SUGARS; MOLECULAR STRUCTURE; PIPERIDINES;

EID: 42149148809     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo800044r     Document Type: Article

References (53)

1. Ishida, N.; Kumagai, K.; Niida, T.; Tsuruoka, T.; Yumate, H. J. Antibiot. 1967, 20, 66-71.
2. (a) Bernotas, R. C.; Papandreou, G.; Urbach,J.; Ganem, B. Tetrahedron Lett. 1990, 31, 3393-3396.
3. (b) Murao, S.; Miyata, S. Agric. Biol. Chem. 1980, 44, 219-221.
4. (c) Yagi, M.; Kouno, T.; Aoyagi, Y.; Murai, H. Nippon Nogei Kagaku Kaishi 1976, 50, 571-572.
5. Koyama, M.; Aijima, T.; Sakamura, S. Agric. Biol. Chem. 1974, 38, 1467-1469.
6. (a) Dong, W.; Jespersen, T.; Bols, M.; Skrydstrup, T.; Sierks, M. R. Biochemistry 1996, 35, 2788-2795.
7. (b) Jespersen, T. M.; Dong, W.; Sierks, M. R.; Skrydstrup, T.; Lundt, I.; Bols, M. Angew. Chem., Int. Ed. Engl. 1994, 33, 1778-1779.
8. (c) Jespersen, T. M.; Bols, M. Tetrahedron 1994, 50, 13449-13460.
9. (d) Ichikawa, Y.; Igarashi, Y. Tetrahedron Lett. 1995, 36, 4585.
10. (e) Bols, M. Acc. Chem. Res. 1998, 31, 1-8.
11. (f) Ichikawa, Y.; Igarashi, Y.; Ichikawa, M.; Suhura, Y. J. Am. Chem. Soc. 1998, 120, 5854.
12. (g) Willams, S. J.; Hoos, R.; Withers, S. G. J. Am. Chem. Soc. 2000, 122, 2223-2235.
13. (h) Nishimura, Y.; Shitara, E.; Adachi, H.; Toyoshima, M.; Nakajima, M.; Okami, Y.; Takeuchi, T. J. Org. Chem. 2000, 65, 2-11.
14. (i) Pandey, G.; Kapur, M.; Khan, M. I.; Gaikwad, S. M. Org. Biomol. Chem. 2003, 1, 3321-3326.
15. (j) Yokoyama, H.; Ejiri, H.; Miyazawa, M.; Yamaguchi, S.; Hirai, Y. Tetrahedron: Asymmetry 2007, 18, 852-856.
16. (k) Steet, R.; Chung, S.; Lee, W.; Pine, C. W.; Do, H.; Kornfeld, S. Biochem. Pharmacol. 2007, 73, 1376-1386.
17. (l) Imahori, T.; Ojima, H.; Tateyama, H.; Mihara, Y.; Takahata, H. Tetrahedron Lett. 2008, 49, 265-268.
18. (a) Kajimoto, T.; Liu, K. K. C.; Pederson, R. L.; Zhong, Z., Jr.; Ichikawa, Y.; Porco, J. A.; Wong, H. J. Am. Chem. Soc. 1991, 113, 6187-6196.
19. (b) Xu, Y.; Zhou, W. J. Chem. Soc., Perkin Trans. 1 1997, 1, 741-746.
20. (c) Asano, N.; Kato, A.; Miyauchi, M.; Kizu, H.; Kameda, Y.; Watson, A. A.; Nash, R. J.; Fleet, G. W. J. J. Nat. Prod. 1998, 61, 625-628.
21. (d) Bols, M.; Lillelund, V. H.; Jensen, H. H.; Liang, X. Chem. Rev. 2002, 102, 515-553 and references cited therein.
22. (e) Elbein, A. D. Annu. Rev. Biochem. 1987, 56, 497-534.
23. (f) Karpas, A.; Fleet, G. W. J.; Dwek, R. A.; Petursson, S.; Namgoong, S. K.; Ramsden, N. G.; Jacob, G. S.; Rademacher, T. W. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 9229-9236.
24. (g) Karpas, A.; Fleet, G. W. J.; Dwek, R. A.; Petursson, S.; Namgoong, S. K.; Ramsden, N. G.; Jacob, G. S.; Rademacher, T. W. FEBS Lett. 1988, 237, 128-132.
25. (h) Fleet, G. W. J. Chem. Ber. 1989, 287-292.
26. (i) Winchester, B.; Fleet, G. W. J. Glycobiology 1992, 2, 199-210.
27. (j) Merror, Y. L.; Poitout, L.; Deepazy, J.; Dosbaa, I.; Geoffroy, S.; Foglietti, M. Bioorg. Med. Chem. 1997, 5, 519-553.
28. (k) Stutz, A. E. Iminosugars as Glycosidase Inhibitors, Nojirimycin and Beyond; Wiley-VCH: Weinheim, 1999.
29. (l) Heightman, T. D.; Vasella, A. T. Angew. Chem., Int. Ed. 1999, 38, 750-770.
30. (m) Goujon, J. Y.; Gueyrard, D.; Philippe, C.; Olivier, M. R.; Asano, N. Tetrahedron: Asymmetry 2003, 14, 1969-1972.
31. (n) Jenson, H. H.; Bols, M. Acc. Chem. Res. 2006, 39, 259-265.
32. (o) Zhou, J.; Zhou, J.; Meng, Y.; Chen, M. J. Chem. Theory Comput. 2006, 2, 157-165.
33. (p) Wicki, J.; Williams, S. J.; Withers, S. G. J. Am. Chem. Soc. 2007, 129, 4530-4531.
34. (q) Gloster, T. M.; Meloncelli, P. R.; Stick, V.; Zechel, D.; Vasella, A.; Davies, G. J. J. Am. Chem. Soc. 2007, 129, 2349-2352.
35. (r) See the recent book on iminosugars: Compain, P., Martin, O. R., Eds. Imunosugars: From synthesis to therapeutic applications; Wiley: New York, 2007.
36. Ichikawa, M.; Igarashi, Y.; Ichikawa, Y. Tetrahedron Lett. 1995, 36, 1767-1770.
37. (a) Dhavale, D. D.; Markad, S. D.; Karanjule, N. S.; PrakashaReddy, J. J. Org. Chem. 2004, 69, 4760-4766.
38. (b) Patil, N. T.; Tilekar, J. N.; Dhavale, D. D. J. Org. Chem. 2001, 66, 1065-1074 and references cited therein.
39. (c) Markad, S. D.; Karanjule, N. S.; Sharma, T.; Sabharwal, S. G.; Dhavale, D. D. Biorg. Med. Chem. 2006, 14, 5535-5539.
40. (d) Matin, M. M.; Sharma, T.; Sabharwal, S. G.; Dhavale, D. D. Org. Biomol. Chem. 2005, 3, 1702-1707.
41. (e) Dhavale, D. D.; Matin, M. M.; Sharma, T.; Sabharwal, S. G. Bioorg. Med. Chem. 2004, 12, 4039-4044.
42. (f) Dhavale, D. D.; Ajish Kumar, K. S.; Chaudhari, V. D.; Sharma, T.; Sabharwal, S. G.; PrakashaReddy, J. Org. Biomol. Chem. 2005, 3, 3720-3726.
43. (g) Ajish Kumar, K. S.; Chaudhari, V. D.; Puranik, V. G.; Dhavale, D. D. Eur. J. Org. Chem. 2007, 29, 4895-4901 and references cited therein.
44. (a) Stefanska, A. L.; Coates, N. J.; Mensah, L. M.; Pope, A. J.; Ready, S. J.; Warr, S. R. J. Antibiot. 2000, 53, 345-350.
45. (b) Walker, G.; Brown, P.; Forrest, A. K.; O'Hanlon, P.; Pons, J. E. Recent Advances in the Chemistry of Anti-infective Agents; Royal Society of Chemistry: London, 1993; p 106.
46. (c) Houge-Frydrych, C. S. V.; Readshaw, S. A.; Bell, D. J. J. Antibiot. 2000, 53, 351-356.
47. (d) Berge, J. M.; Broom, N. J. P.; Houge-Frydrych, C. S. V.; Jarvest, R. L.; Mensah, L.; McNair, D. J.; O'Hanlon, P. J.; Pope, A. J.; Rittenhouse, S. J. Antibiot. 2000, 53, 1282-1292.
48. (e) Berge, J. M.; Copley, R. C. B.; Eggleston, D. S.; Hamprecht, D. W.; Jarvest, R. L.; Mensah, L. M.; O', Hanlon, P. J.; Pope, A. J. Bioorg. Med. Chem. Lett. 2000, 10, 1811-1814.
49. (f) Berge, J. M.; Catherine, S. V.; Houge-Frydrych, C. S. V.; Jarvest, R. L. J. Chem. Soc., Perkin Trans. 1 2001, 20, 2521-2523.
50. (a) Hotha, S.; Maurya, S. K.; Gurjar, M. K. Tetrahedron Lett. 2005, 46, 5329-5332.
51. Compound 7 is reported using different methodology, see: Pinheiro, J. M.; Ismael, M. I.; Figueiredo, J. A.; Silva, A. M. S. J. Heterocycl. Chem. 2004, 41, 877-882.
52. 13C NMR spectra of compounds 8, 9, 10, 11, 12, 13, 14, and 15 in which a N-Cbz group is present, showed doubling of signals. This was due to restricted rotation around the N-C=O bond, see: (a) Applications of NMR Spectroscopy in Organic Chemistry; Jackman, L. M., Sternhell, S., Eds.; Pergamon Press: Elmsford, NY, 1978; p 361.
53. While our work was in progress, Hanessian et al. have reported the synthesis of 3a-methoxy-N-Bus bicyclic oxapiperidine, analogous to compound 12, using different methodology, see: Loiseleur, O.; Ritson, D.; Nina, M.; Crowley, P.; Wagner, T.; Hanessian, S. J. Org. Chem. 2007, 72, 6353-6363.